Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords

Takeda Pharmaceutical GAAP EPS of ¥150.00, revenue of ¥1.06T

Jul. 27, 2023 6:45 AM ETTakeda Pharmaceutical Company Limited (TAK)By: Deepa Sarvaiya, SA News Editor
  • Takeda Pharmaceutical press release (NYSE:TAK): Q1 GAAP EPS of ¥150.00
  • Revenue of ¥1.06T (+8.9% Y/Y).
  • Revenue Growth of +8.9% at Actual Exchange Rate (AER); +3.7% Growth at Constant Exchange Rate (CER), Driven by Growth & Launch Products (+16.2% at CER)

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

More Trending News

See More »

About TAK

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TAK--
Takeda Pharmaceutical Company Limited
DSNKY--
Daiichi Sankyo Company, Limited
BAYRY--
Bayer Aktiengesellschaft
ALPMY--
Astellas Pharma Inc.
OTSKY--
Otsuka Holdings Co., Ltd.
Compare

Trending Analysis

Trending News

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.